In this issue:
- The trouble with being a cure-all Its reputation as a panacea creates product liability concerns for the stem cell
- Which product-safety data is admissible? Depending on the situation, such evidence can be either crucial or unreliable
- Pennsylvania wrestling anew with an old question: venue What happens if a ban on venue-shopping in medical malpractice cases is eliminated?
- Why electronic cigarettes are the next mass tort What you need to know about e-cigs—and why they’re the next mass tort
The Product Liability Playbook is a collaborative effort of Goldberg Segalla’s Product Liability practice examining the latest practices, emerging developments, and influential court decisions in product liability law.